Member Info for Scoobydoo321

It's more to do with the overall small cap market at the mo.

Unlike many other AIM companies, Ffwd's is back up with a NAV that is seriously undervalued.

Nice one hstcks2

How is LLAI as a competitor to ONC's blood test for lung cancer?
LLAI just got listed today.
Admission doc below.
https://investors.lunglifeai.com/wp-content/uploads/2021/07/LungLife-AI-Pricing-Confirmation-and-publication-of-AD-02.07.21.pdf
Just wondering if any LTH of ONC has any insight.

PIs were still buying on the back of the potential exosomes partnerships at high 140sp a few months ago.

Not much has changed since then.

If so, Consideration for Leap with Endeavor shares + cash combo perhaps?

MV 7mn pounds.

If samples turn out to be positive - does anyone know how far this could go? Next Marfonteine?

Good point Llad.

Btw - anyone clued on as to whether Ffwd is in the money and if so by how much w.r.t Yooma.

Per Stockopedia
Market Cap £36.25m
Enterprise Value £29.72m
= huge upside at these prices

FDA Clearance decision - H2 this year - so any time from now to Dec end.

26/8/20
https://www.lse.co.uk/rns/RENX/submission-seeking-fda-clearance-of-kidneyintelx-hmr8mcl9lmj8gi6.html

15/6/21
Per
https://seekingalpha.com/article/4434994-renalytix-ai-plc-rnlx-ceo-james-mccullough-on-q3-2021-results-earnings-call-transcript

James says - We expect the pace of milestone events to continue into the first half of fiscal 2022 beginning in this July, including a potential FDA clearance, additional major health system partnership announcements, beginning operations in the VA medical system, increasing our portfolio of real world evidence data, particularly at the all important primary care level, potential national Medicare coverage determination, and an acceleration in KidneyIntelX testing volumes.

On to our regulatory partnership and operations progress, the Food and Drug Administration has reinitiated review of the KidneyIntelX final submission under breakthrough device ahead of their previously targeted April 15 deadline, following a sector-wide COVID delay. Our regulatory review team and outside advisors will continue to diligently respond to any remaining FDA questions until the conclusion of the breakthrough review. While we can make no guarantees on timing or outcome, we are gearing our internal plans based on an assumption that the FDA process will be complete in the second half of this 2021 calendar year.

You know things are perking up when daily transactions > daily posts on BB !
:)

So much Karma here on this BB whilst waiting for the golden RNS - compare it to the bloodshed at Orph whilst PIs waiting for the golden RNS.

LOL - bring out the Dom Perignon - it's a blue day!!!!!!!!!!!!

Havent had a good laugh about the markets for around 6 weeks

This is insanity. SP is reacting as if Orph has given a profit warning!

they are algorithm bots trades

Gosh...it's like Avct Vs Orph
Waiting for that golden RNS

George did say that he is "confident" in the African Weekly prior to flying out.
I assume that it was a PR stunt recommended by their investor relations agents.
You would only carry out such a stunt if you have foreknowledge that it's a done deal.
Don't forget that George holds 7%+ ownership.

On the other hand, if you were uncertain that the deal would be done with the Burundi gov, George would have most probably made a hush flight and negotiated in privacy without letting journalists know first.

So unless the issues are unforeseen, IMO the issues have been resolved. Bring the colours back to rainbow George.

The last spin off did not stir much encouragement. If I am not mistaken, from memory - the SP fell from c37p to 30p ex div. Bit of a shocker really. So I am extremely wary of the next spin off's effect on SP

I think this SP fall has zilch to do with covid play. CF has stressed many times before as well so PIs should be drilled in with that fact.

To use it, IMO would be a narrative fallacy.

In fact, wr.t gov, have they not placed increased emphasis on identifying variants and possible mutations in anticipation of autumn/winter spike which infers possibly more +ves for Orph than negatives.

RTO sellers - relentless - even at these SPs!

05-Jul-21 16:10:12 17.00 125,000 Sell* 17.00 18.00 21.25k

blimey - they are buys rather than sells! me finks